- Home
- MEI vs IMMP Comparison
MEI vs IMMP Comparison
Compare MEI & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEI
- IMMP
- Stock Information
- Founded
- MEI 1946
- IMMP 1987
- Country
- MEI United States
- IMMP Australia
- Employees
- MEI N/A
- IMMP N/A
- Industry
- MEI Electrical Products
- IMMP Biotechnology: Pharmaceutical Preparations
- Sector
- MEI Technology
- IMMP Health Care
- Exchange
- MEI Nasdaq
- IMMP Nasdaq
- Market Cap
- MEI 238.4M
- IMMP 211.1M
- IPO Year
- MEI N/A
- IMMP N/A
- Fundamental
- Price
- MEI $7.86
- IMMP $1.89
- Analyst Decision
- MEI Buy
- IMMP Buy
- Analyst Count
- MEI 2
- IMMP 2
- Target Price
- MEI $10.50
- IMMP $8.50
- AVG Volume (30 Days)
- MEI 308.9K
- IMMP 659.8K
- Earning Date
- MEI 07-10-2025
- IMMP 05-23-2025
- Dividend Yield
- MEI 7.14%
- IMMP N/A
- EPS Growth
- MEI N/A
- IMMP N/A
- EPS
- MEI N/A
- IMMP N/A
- Revenue
- MEI $1,068,300,000.00
- IMMP $3,019,249.00
- Revenue This Year
- MEI N/A
- IMMP $50.37
- Revenue Next Year
- MEI $1.16
- IMMP N/A
- P/E Ratio
- MEI N/A
- IMMP N/A
- Revenue Growth
- MEI N/A
- IMMP 24.11
- 52 Week Low
- MEI $5.08
- IMMP $1.32
- 52 Week High
- MEI $17.45
- IMMP $3.34
- Technical
- Relative Strength Index (RSI)
- MEI 71.97
- IMMP 54.39
- Support Level
- MEI $6.35
- IMMP $1.78
- Resistance Level
- MEI $7.16
- IMMP $2.71
- Average True Range (ATR)
- MEI 0.27
- IMMP 0.17
- MACD
- MEI 0.23
- IMMP 0.02
- Stochastic Oscillator
- MEI 94.97
- IMMP 25.45
About MEI Methode Electronics Inc.
Methode Electronics Inc makes component and subsystem devices employing electrical, radio remote control, electronic, wireless, and sensing technologies. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles. The products manufactured in the automotive segment include overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors. Geographically, the company generates maximum revenue from North America and the rest from Europe, the Middle East & Africa (EMEA), and Asia.
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.